We are live on
!
Find out more
DA
DCF Advisers Portfolio holdings
AUM
$375M
1-Year Est. Return
72.65%
This Fund
S&P 500
This Quarter
Est. Return
+5.2%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$250M
AUM Growth
+$56M
(+29%)
Cap. Flow
+$44.7M
Cap. Flow
% of AUM
17.87%
Top 10 Holdings %
Top 10 Hldgs %
51.39%
Holding
108
New
15
Increased
21
Reduced
34
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.19M |
| 2 |
Micron Technology
MU
|
+$1.73M |
| 3 |
Citigroup
C
|
+$1.45M |
| 4 |
Sprott Uranium Miners ETF
URNM
|
+$1.1M |
| 5 |
Amgen
AMGN
|
+$818K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.95M |
| 2 |
Apple
AAPL
|
+$2.23M |
| 3 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$1.15M |
| 4 |
SPDR Gold Trust
GLD
|
+$916K |
| 5 |
Biohaven
BHVN
|
+$805K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.92% |
| 2 | Technology | 16.18% |
| 3 | Communication Services | 7.16% |
| 4 | Consumer Discretionary | 6.33% |
| 5 | Financials | 3.42% |
Similar funds
JIC
CIM
AIM
MWM
RCP
HPM
CAG
LWMNY
DCF Advisers's Q3 2024 Portfolio in Review
As of Q3 2024, DCF Advisers held 108 positions worth $250M, up 29% from $194M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
DCF Advisers deployed $44.7M of net new capital in Q3 2024, opening 15 new positions and adding to 21 existing holdings. Its largest new stake was NewAmsterdam Pharma: 34,000 shares worth $564K.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 34% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $2.95M trimmed.
- DCF Advisers's largest Q3 2024 buy was NewAmsterdam Pharma: 34,000 shares worth $564K.
- DCF Advisers added most to Amazon in Q3 2024, an estimated $3.19M increase.
- DCF Advisers's biggest Q3 2024 reduction was Regeneron Pharmaceuticals, cutting an estimated $2.95M.
- DCF Advisers fully exited Snowflake in Q3 2024, selling an estimated $439K.
- DCF Advisers's ten largest holdings make up 51% of its $250M portfolio in Q3 2024.
- DCF Advisers opened 15 new positions and closed 11 in Q3 2024.
- DCF Advisers's portfolio value rose 29% quarter-over-quarter to $250M.
Based on DCF Advisers's 13F filing for Q3 2024, filed 13 Nov 2024.